New Therapeutic Solutions
Embedded Files
NANO. TARGETED. INTELLIGENT.
ArthroTarget develops a magnetically controllable nanoparticle platform for locally targeted drug delivery, aiming to enable more precise and resource-efficient therapeutic concepts. The current development focus lies on joint-related diseases, particularly osteoarthritis; additional local indications are evaluated prospectively.
👥
Around 600 million people worldwide and 17.9% of adults in Germany live with osteoarthritis and similar joint diseases.
❌
Numerous existing therapies do not provide long-term relief. Patients undergo expensive, painful, and often ineffective treatments.
💶
Access to innovative methods is often limited to those who can afford it. This burdens not only the patients but the entire healthcare system.
⏳
Valuable time, money, and medical personnel are wasted through unsystematic, non-targeted therapies.
Why ArthroTarget?
A platform approach for targeted drug delivery
Addressable Nanoplatforms
Local Application Approaches
Precise Targeting
Time-Dependent Release Profiles
The ArthroTarget platform is based on addressable nanocarrier systems that enable locally focused and controlled drug application. By combining external controllability, precise spatial targeting, and temporally adjustable drug release profiles, the platform aims to spatially concentrate therapeutic effects while reducing systemic exposure.
Integrated into a robust ecosystem of research and innovation
Page updated
Report abuse